S&P 500   3,374.68 (+0.04%)
DOW   27,882.84 (-0.05%)
QQQ   271.23 (-0.46%)
AAPL   453.30 (-1.47%)
MSFT   207.79 (-0.44%)
FB   259.50 (-0.69%)
GOOGL   1,506.00 (-0.70%)
AMZN   3,130.91 (-0.95%)
NVDA   461.74 (+0.88%)
CGC   17.09 (-1.33%)
BABA   252.76 (-0.38%)
TSLA   1,647.36 (+1.63%)
GE   6.69 (+1.36%)
MU   45.65 (-1.06%)
AMD   82.19 (+0.43%)
T   30.02 (+0.37%)
F   7.07 (+0.57%)
GILD   68.42 (+0.35%)
NFLX   481.74 (+0.09%)
DIS   131.05 (+0.07%)
BAC   26.45 (+0.38%)
BA   177.75 (+1.73%)
S&P 500   3,374.68 (+0.04%)
DOW   27,882.84 (-0.05%)
QQQ   271.23 (-0.46%)
AAPL   453.30 (-1.47%)
MSFT   207.79 (-0.44%)
FB   259.50 (-0.69%)
GOOGL   1,506.00 (-0.70%)
AMZN   3,130.91 (-0.95%)
NVDA   461.74 (+0.88%)
CGC   17.09 (-1.33%)
BABA   252.76 (-0.38%)
TSLA   1,647.36 (+1.63%)
GE   6.69 (+1.36%)
MU   45.65 (-1.06%)
AMD   82.19 (+0.43%)
T   30.02 (+0.37%)
F   7.07 (+0.57%)
GILD   68.42 (+0.35%)
NFLX   481.74 (+0.09%)
DIS   131.05 (+0.07%)
BAC   26.45 (+0.38%)
BA   177.75 (+1.73%)
S&P 500   3,374.68 (+0.04%)
DOW   27,882.84 (-0.05%)
QQQ   271.23 (-0.46%)
AAPL   453.30 (-1.47%)
MSFT   207.79 (-0.44%)
FB   259.50 (-0.69%)
GOOGL   1,506.00 (-0.70%)
AMZN   3,130.91 (-0.95%)
NVDA   461.74 (+0.88%)
CGC   17.09 (-1.33%)
BABA   252.76 (-0.38%)
TSLA   1,647.36 (+1.63%)
GE   6.69 (+1.36%)
MU   45.65 (-1.06%)
AMD   82.19 (+0.43%)
T   30.02 (+0.37%)
F   7.07 (+0.57%)
GILD   68.42 (+0.35%)
NFLX   481.74 (+0.09%)
DIS   131.05 (+0.07%)
BAC   26.45 (+0.38%)
BA   177.75 (+1.73%)
S&P 500   3,374.68 (+0.04%)
DOW   27,882.84 (-0.05%)
QQQ   271.23 (-0.46%)
AAPL   453.30 (-1.47%)
MSFT   207.79 (-0.44%)
FB   259.50 (-0.69%)
GOOGL   1,506.00 (-0.70%)
AMZN   3,130.91 (-0.95%)
NVDA   461.74 (+0.88%)
CGC   17.09 (-1.33%)
BABA   252.76 (-0.38%)
TSLA   1,647.36 (+1.63%)
GE   6.69 (+1.36%)
MU   45.65 (-1.06%)
AMD   82.19 (+0.43%)
T   30.02 (+0.37%)
F   7.07 (+0.57%)
GILD   68.42 (+0.35%)
NFLX   481.74 (+0.09%)
DIS   131.05 (+0.07%)
BAC   26.45 (+0.38%)
BA   177.75 (+1.73%)
Log in

NYSE:COOCooper Companies Stock Price, Forecast & News

$305.49
+0.59 (+0.19 %)
(As of 08/14/2020 10:54 AM ET)
Add
Compare
Today's Range
$301.71
Now: $305.49
$306.02
50-Day Range
$270.93
MA: $288.66
$306.83
52-Week Range
$236.68
Now: $305.49
$365.68
Volume3,058 shs
Average Volume350,851 shs
Market Capitalization$16.29 billion
P/E Ratio44.47
Dividend Yield0.02%
Beta0.89
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier preimplantation genetic screening, preimplantation genetic diagnosis, and screening used in IVF process; micro pipettes; IVF medical devices and systems; and PARAGARD, a contraceptive option. It markets its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.
Read More
Cooper Companies logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 4.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.52 out of 5 stars


Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP21664840
Phone925-460-3600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.65 billion
Cash Flow$18.22 per share
Book Value$73.20 per share

Profitability

Net Income$466.70 million

Miscellaneous

Employees12,000
Market Cap$16.29 billion
Next Earnings Date9/3/2020 (Confirmed)
OptionableOptionable
$305.49
+0.59 (+0.19 %)
(As of 08/14/2020 10:54 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive COO News and Ratings via Email

Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cooper Companies (NYSE:COO) Frequently Asked Questions

How has Cooper Companies' stock price been impacted by Coronavirus (COVID-19)?

Cooper Companies' stock was trading at $323.89 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, COO shares have decreased by 5.7% and is now trading at $305.49.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Cooper Companies?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Cooper Companies
.

When is Cooper Companies' next earnings date?

Cooper Companies is scheduled to release its next quarterly earnings announcement on Thursday, September 3rd 2020.
View our earnings forecast for Cooper Companies
.

How can I listen to Cooper Companies' earnings call?

Cooper Companies will be holding an earnings conference call on Thursday, September 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Cooper Companies' earnings last quarter?

Cooper Companies Inc (NYSE:COO) issued its earnings results on Thursday, June, 4th. The medical device company reported $1.51 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.29 by $0.78. The medical device company earned $524.90 million during the quarter, compared to the consensus estimate of $604.78 million. Cooper Companies had a net margin of 13.50% and a return on equity of 14.67%. Cooper Companies's quarterly revenue was down 19.7% on a year-over-year basis. During the same quarter last year, the business posted $2.94 EPS.
View Cooper Companies' earnings history
.

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies declared a Semi-Annual dividend on Thursday, July 9th. Investors of record on Thursday, July 23rd will be given a dividend of $0.03 per share on Friday, August 7th. The ex-dividend date of this dividend is Wednesday, July 22nd.
View Cooper Companies' dividend history
.

What price target have analysts set for COO?

11 brokerages have issued twelve-month price targets for Cooper Companies' stock. Their forecasts range from $291.00 to $351.00. On average, they anticipate Cooper Companies' share price to reach $330.73 in the next year. This suggests a possible upside of 8.3% from the stock's current price.
View analysts' price targets for Cooper Companies
.

Has Cooper Companies been receiving favorable news coverage?

Media headlines about COO stock have been trending positive recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cooper Companies earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned media headlines about the medical device company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near term.
View the latest news about Cooper Companies
.

Are investors shorting Cooper Companies?

Cooper Companies saw a decrease in short interest in the month of February. As of February 28th, there was short interest totaling 790,500 shares, a decrease of 19.6% from the February 13th total of 983,600 shares. Based on an average trading volume of 297,800 shares, the short-interest ratio is presently 2.7 days.
View Cooper Companies' Short Interest
.

Who are some of Cooper Companies' key competitors?

What other stocks do shareholders of Cooper Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cooper Companies investors own include AbbVie (ABBV), Boeing (BA), Netflix (NFLX), NVIDIA (NVDA), Adobe (ADBE), Gilead Sciences (GILD), Alibaba Group (BABA), Amgen (AMGN), Intel (INTC) and Broadcom (AVGO).

Who are Cooper Companies' key executives?

Cooper Companies' management team includes the following people:
  • Mr. Albert G. White III, Pres, CEO & Director (Age 49)
  • Mr. Brian G. Andrews, Sr. VP, CFO & Treasurer (Age 40)
  • Mr. Daniel G. McBride, Exec. VP & COO (Age 55)
  • Ms. Holly R. Sheffield, Exec. VP & Chief Strategy Officer (Age 48)
  • Dr. Robert D. Auerbach, Pres of Coopersurgical Inc (Age 58)

What is Cooper Companies' stock symbol?

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

Who are Cooper Companies' major shareholders?

Cooper Companies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.85%), FIL Ltd (1.89%), Bessemer Group Inc. (1.10%), Goldman Sachs Group Inc. (1.02%), California Public Employees Retirement System (0.77%) and Victory Capital Management Inc. (0.72%). Company insiders that own Cooper Companies stock include A Thomas Bender, Agostino Ricupati, Albert G White III, Allan E Rubenstein, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Holly R Sheffield, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg.
View institutional ownership trends for Cooper Companies
.

Which major investors are selling Cooper Companies stock?

COO stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Marshall Wace LLP, Viking Global Investors LP, Bank of Montreal Can, Kornitzer Capital Management Inc. KS, FIL Ltd, FMR LLC, and Frontier Capital Management Co. LLC. Company insiders that have sold Cooper Companies company stock in the last year include Allan E Rubenstein, Jody S Lindell, and Michael Kalkstein.
View insider buying and selling activity for Cooper Companies
.

Which major investors are buying Cooper Companies stock?

COO stock was bought by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Ceredex Value Advisors LLC, Vanguard Group Inc., Bessemer Group Inc., Robeco Institutional Asset Management B.V., Russell Investments Group Ltd., First Trust Advisors LP, and PGGM Investments. Company insiders that have bought Cooper Companies stock in the last two years include Agostino Ricupati, Albert G White III, Allan E Rubenstein, and Holly R Sheffield.
View insider buying and selling activity for Cooper Companies
.

How do I buy shares of Cooper Companies?

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cooper Companies' stock price today?

One share of COO stock can currently be purchased for approximately $305.49.

How big of a company is Cooper Companies?

Cooper Companies has a market capitalization of $16.29 billion and generates $2.65 billion in revenue each year. The medical device company earns $466.70 million in net income (profit) each year or $12.35 on an earnings per share basis. Cooper Companies employs 12,000 workers across the globe.

What is Cooper Companies' official website?

The official website for Cooper Companies is www.coopercos.com.

How can I contact Cooper Companies?

Cooper Companies' mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.